UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15 (d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date
of Report (Date of earliest event reported): April 17, 2008
PFIZER
INC.
(Exact
name of registrant as specified in its charter)
|
Delaware |
1-3619 |
13-5315170 |
|
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
|
235 East 42nd Street New York, New York |
10017 |
|
(Address of principal executive offices) |
|
Registrant’s telephone number, including area code:
(212)
573-2323
Not Applicable
(Former Name or Former Address, if
changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
⃞ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
⃞ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
⃞ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
⃞ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item
2.02 Results of Operations and Financial Condition.
On
April 17, 2008, Pfizer Inc. (“Pfizer”) issued a press release announcing
its financial results for the first quarter of 2008. The information
contained in the press release is deemed to be “filed” under the
Securities Exchange Act of 1934 as Exhibit 99 to this report, and such
press release is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
|
Exhibit 99 - |
Press Release of Pfizer Inc. dated April 17, 2008, reporting Pfizer's financial results for the first quarter of 2008. Exhibit 99 is deemed to be “filed” under the Securities Exchange Act of 1934 in this Current Report on Form 8-K. |
SIGNATURE
Under the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the authorized undersigned.
|
PFIZER INC. |
||||
|
|
||||
|
|
|
By: |
/s/ Margaret M. Foran |
|
|
Margaret M. Foran |
||||
| Title: |
Senior Vice President-Corporate Governance, |
|||
|
Associate General Counsel and Corporate Secretary |
||||
|
Dated: |
April 17, 2008 |
|||
EXHIBIT INDEX
|
Exhibit No. |
Description |
| 99 |
Press Release of Pfizer Inc. dated April 17, 2008, reporting Pfizer's financial results for the first quarter of 2008. |